<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>Case Studies | Oxbridge Psychometrics</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="Selected case studies demonstrating how Oxbridge Psychometrics supports regulatory-grade evidence development for pharmaceutical products." />

  <style>
    body {
      margin: 0;
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Arial, sans-serif;
      color: #1f2937;
      background: #ffffff;
      line-height: 1.6;
    }

    header {
      padding: 50px 20px;
      background: #f9fafb;
      text-align: center;
    }

    header h1 {
      font-size: 2.3rem;
      margin-bottom: 14px;
    }

    header p {
      max-width: 820px;
      margin: auto;
      font-size: 1.1rem;
      color: #4b5563;
    }

    section {
      max-width: 1000px;
      margin: auto;
      padding: 44px 20px;
    }

    .case {
      border-left: 4px solid #1d4ed8;
      padding: 22px;
      margin-bottom: 32px;
      background: #ffffff;
      border-radius: 6px;
    }

    .case h2 {
      margin-top: 0;
      margin-bottom: 6px;
    }

    .label {
      font-weight: 600;
      margin-top: 14px;
    }

    footer {
      text-align: center;
      padding: 24px;
      font-size: 0.9rem;
      color: #6b7280;
      background: #f9fafb;
    }

    a {
      color: #1d4ed8;
      text-decoration: none;
      font-weight: 600;
    }
  </style>
</head>

<body>

<header>
  <h1>Case Studies</h1>
  <p>
    Selected examples illustrating how Oxbridge Psychometrics has supported
    pharmaceutical programmes through rigorous psychometric methodology
    and regulator-aligned evidence development.
  </p>
</header>

<section>

  <div class="case">
    <h2>Development of a Patient-Reported Outcome Measure</h2>

    <p class="label">Context</p>
    <p>
      A pharmaceutical sponsor required a new patient-reported outcome instrument
      to capture treatment benefits not fully reflected in clinical endpoints.
    </p>

    <p class="label">Our Contribution</p>
    <p>
      Development of a fit-for-purpose questionnaire including conceptual framework
      development, item generation, and psychometric evaluation aligned with FDA PRO guidance.
    </p>

    <p class="label">Advantage Delivered</p>
    <p>
      Strong evidence of content validity, reliability, and sensitivity to change,
      supporting regulatory-facing analyses.
    </p>
  </div>

  <div class="case">
    <h2>Psychometric Evaluation to Strengthen Regulatory Evidence</h2>

    <p class="label">Context</p>
    <p>
      Existing outcome data required additional psychometric justification to meet
      regulatory expectations for interpretation and use.
    </p>

    <p class="label">Our Contribution</p>
    <p>
      Detailed evaluation of measurement properties including construct validity,
      internal consistency, and responsiveness.
    </p>

    <p class="label">Advantage Delivered</p>
    <p>
      Clear, regulator-ready justification supporting the credibility of outcome measures
      within the overall evidence package.
    </p>
  </div>

  <div class="case">
    <h2>Optimisation of Outcome Strategy Across a Development Programme</h2>

    <p class="label">Context</p>
    <p>
      A development programme required alignment of outcome measurement strategy
      across multiple studies and timepoints.
    </p>

    <p class="label">Our Contribution</p>
    <p>
      Strategic input on outcome selection, measurement timing, and psychometric evidence
      requirements to ensure consistency and regulatory relevance.
    </p>

    <p class="label">Advantage Delivered</p>
    <p>
      A coherent, defensible outcome strategy supporting interpretation of patient benefit
      across the programme lifecycle.
    </p>
  </div>

</section>

<footer>
  © 2026 Oxbridge Psychometrics ·
  <a href="/">Back to Home</a>
</footer>

</body>
</html>
